e-ISSN: Pending
Negative / Null Result ReportOpen accessEconomics, Econometrics and Finance· cited by 14

Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe

Courtney Davis; Anita K. Wagner; Maximilian Salcher‐Konrad; Henry Scowcroft; Barbara Mintzes; Adrian Pokorny; Jianhui Lew; Huseyin Naci · 2023 · BMJ

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

OBJECTIVE: To evaluate the frequency with which relevant and accurate information about the benefits and related uncertainties of anticancer drugs are communicated to patients and clinicians in regulated information sources in Europe. DESIGN: Document content analysis. SETTING: European Medicines Agency. PARTICIPANTS: Anticancer drugs granted a first marketing authorisation by the European Medicines Agency, 2017-19. MAIN OUTCOME MEASURES: Whether written information on a product addressed patients' commonly asked questions about: who and what the drug is used for; how the drug was studied; typ

Abstract by Courtney Davis; Anita K. Wagner; Maximilian Salcher‐Konrad; Henry Scowcroft; Barbara Mintzes; Adrian Pokorny; Jianhui Lew; Huseyin Naci, BMJ (2023) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1136/bmj-2022-073711